Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723741 | SCV000112773 | uncertain significance | not provided | 2014-12-05 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000192004 | SCV000151561 | uncertain significance | not specified | 2015-02-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001086548 | SCV000288161 | benign | Spastic paraplegia | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313770 | SCV000848553 | likely benign | Inborn genetic diseases | 2016-03-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000723741 | SCV001832987 | benign | not provided | 2018-11-27 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000723741 | SCV001927706 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000723741 | SCV001963857 | likely benign | not provided | no assertion criteria provided | clinical testing |